The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Be By 2030 Compared To Its 2026 Market Size?
The arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market has seen swift expansion over recent years. This market is expected to increase from $1.52 billion in 2025 to $1.79 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.5%. Historically, this growth can be ascribed to several factors, including the broadened scope of functional genomics research, the widespread availability of crispr editing reagents, the proliferation of academic screening programs, the early uptake of arrayed screening formats, and the rising utilization of cell-based assays.
The arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market size is anticipated to undergo substantial expansion in the upcoming years. It is projected to achieve a value of $3.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.7%. The predicted growth over the forecast period stems from factors such as increasing demand for precision drug discovery, escalating investments in gene therapy research, the broadening of disease modeling applications, the increasing adoption of bioinformatics-driven screening, and strengthened collaboration between academia and industry. Significant trends identified for the forecast period involve a rising demand for targeted gene validation screens, the increasing deployment of high-throughput arrayed crispr assays, enhanced integration of phenotypic data analytics, the expansion of custom crispr screening services, and a more pronounced focus on functional genomics accuracy.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33018&type=smp
Which Factors Are Influencing The Growth Of The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
The expanding emphasis on personalized medicine is projected to boost the expansion of the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market in the coming years. This medical strategy involves tailoring treatment and prevention plans to an individual’s unique genetic, biological, and lifestyle traits. The embrace of personalized medicine is on the rise, spurred by advancements in genomics and molecular diagnostics that enable treatments to be customized according to an individual’s genetic profile for enhanced results. Arrayed CRISPR screening supports personalized medicine by methodically assessing the impact of specific gene modifications on individual cellular responses. This facilitates the discovery of patient-specific drug targets, the prediction of treatment efficacy, and the creation of customized therapies informed by a person’s genetic and cellular makeup. For example, as reported in February 2024 by the Personalized Medicine Coalition, a US-based non-profit organization, the FDA sanctioned 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. The personalized treatments approved in 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Consequently, the heightened attention on personalized medicine is fueling the growth of the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market.
What Are The Different Segment Types In The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Segment Breakdown?
The arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market covered in this report is segmented –
1) By Product Type: Clustered Regularly Interspaced Short Palindromic Repeats Libraries; Reagents And Consumables; Instruments; Software And Services
2) By Application: Functional Genomics; Drug Discovery; Disease Modeling; Gene Validation; Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Other End Users
Subsegments:
1) By Clustered Regularly Interspaced Short Palindromic Repeats Libraries: Genome Wide Knockout Libraries; Targeted Gene Libraries; Activation Libraries; Repression Libraries; Custom Designed Libraries
2) By Reagents And Consumables: Guide Ribonucleic Acid Reagents; Cas Enzyme Reagents; Transfection Reagents; Cell Culture Reagents; Assay And Detection Reagents
3) By Instruments: Automated Liquid Handling Systems; High Throughput Screening Systems; Cell Imaging Systems; Flow Cytometry Instruments; Genomic Analysis Instruments
4) By Software And Services: Screening Design Software; Data Analysis Software; Bioinformatics Services; Screening Execution Services; Custom Assay Development Services
Which Trends Are Influencing Demand In The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
Leading companies in the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market are increasingly forming strategic alliances to boost the accuracy of high-throughput phenotypic screening. A strategic partnership involves a structured collaboration where organizations merge resources, expertise, or technologies to achieve mutual goals, fostering quicker innovation, mitigating risks, and expanding market presence without a merger or acquisition. For instance, in November 2023, AstraZeneca Plc, a UK-based science-led biopharmaceutical company, entered a partnership with the Medical Research Council (MRC), a UK-based government agency, and the Milner Therapeutics Institute (MTI) at the University of Cambridge, a UK-based biomedical research institute, to establish the Functional Genomics Screening Laboratory (FGSL). This state-of-the-art facility is designed to accelerate drug discovery, aiming to map gene-phenotype connections in chronic conditions such as cardiovascular and metabolic disorders, thereby strengthening the UK’s leadership in genomics through open academic collaborations. Key advantages include high-throughput automation, providing precise imaging and phenotyping for organoids or iPSCs and outperforming pooled methods. Additional benefits encompass free access for researchers, accelerated target validation, and the sharing of expertise to speed up the development of therapies.
Who Are The Well-Known Companies In The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
Major companies operating in the arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market are Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc, Applied Biological Materials Inc, Agilent Technologies Inc, Charles River Laboratories International Inc, Integrated DNA Technologies Inc, GenScript Biotech Corporation, Synthego Holdings LLC, Santa Cruz Biotechnology Inc, Creative Biolabs Inc, VectorBuilder Inc, Admera Health LLC, Addgene Inc, Ncardia, BioCat GmbH, Cellecta Inc, GeneCopoeia Inc, Creative Biogene Inc, and Aelian Biotechnology.
Get The Full Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report:
Which Region Accounts For The Largest Portion Of The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
North America was the largest region in the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=33018&type=smp
Browse Through More Reports Similar to the Global Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market 2026, By The Business Research Company
Crispr Technology Market 2026
https://www.thebusinessresearchcompany.com/report/crispr-technology-market
Crispr Gene Editing Market Report 2026
https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report
Crispr And Cas Gene Market Report 2026
https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model